Rapid generation and selection of Cas9-engineering TRP53 R172P mice that do not have off-target effects.
Guoxing ZhengQingqing ZhuJunchao DongXin LinChengming ZhuPublished in: BMC biotechnology (2019)
A single injection of the this optimized CRISPR/Cas9 system can be applied to introduce particular mutations in the genome of mice without off-target effects to model various human diseases.